
Steven F. Maier
· Distinguished Professor • Director of the Center for NeuroscienceVerifiedUniversity of Colorado Boulder · Psychology & Neuroscience
Active 1967–2025
About
Professor Steven F. Maier is a distinguished professor in the Department of Psychology and Neuroscience at the University of Colorado Boulder. He serves as the Director of the Center for Neuroscience and is recognized for his active involvement in research, despite being retired and no longer taking students. His educational background includes a PhD from the University of Pennsylvania, obtained in 1968. Professor Maier's research interests focus on the neurochemistry and neuropharmacology of stress, drug addiction, and the bi-directional communication between the brain and the immune system, with a particular emphasis on psychoneuroimmunology. His work contributes to understanding the complex interactions between neural and immune processes, advancing knowledge in behavioral neuroscience.
Research topics
- Medicine
- Neuroscience
- Biology
- Immunology
- Psychiatry
- Psychology
- Internal medicine
- Anesthesia
- Cognitive science
- Physical therapy
- Cognitive psychology
- Social psychology
- Mathematics
Selected publications
NeuroImmunoModulation · 2025-03-03 · 2 citations
articleOpen accessINTRODUCTION: The microbiome-gut-brain axis, by modulating bidirectional immune, metabolic, and neural signaling pathways in the host, has emerged as a target for the prevention and treatment of psychiatric and neurological disorders. Oral administration of the probiotic bacterium Lactobacillus rhamnosus GG (LGG; ATCC 53103) exhibits anti-inflammatory effects, although the precise mechanisms by which LGG benefits host physiology and behavior are not known. The goal of this study was to explore the general effects of LGG on the cerebrospinal fluid (CSF) proteome and a biological signature of anti-inflammatory signaling in the central nervous system (CNS) of undisturbed, adult male rats. METHODS: Liquid chromatography-tandem mass spectrometry-based proteomics were conducted using CSF samples collected after 21 days of oral treatment with live LGG (3.34 × 107 colony-forming units (CFU)/mL in the drinking water (resulting in an estimated delivery of ∼1.17 × 109 CFU/day/rat) or water vehicle. Gene enrichment analysis (using DAVID, v. 6.8) and protein-protein interactions (using STRING, v. 11) were used to explore physiological network changes in CSF. Real-time reverse transcription polymerase chain reaction (real-time RT-PCR) was performed to assess gene expression changes of anti-inflammatory cytokines in the hippocampus. Genes associated with anti-inflammatory signaling that were analyzed included Il10, Tgfb1, Il4, and IL-4-responsive genes, Cd200, Cd200r1, and Mrc1 (Cd206). RESULTS: Oral LGG administration altered the abundance of CSF proteins, increasing the abundance of five proteins (cochlin, NPTXR, reelin, Sez6l, and VPS13C) and decreasing the abundance of two proteins (CPQ, IGFBP-7) in the CSF. Simultaneously, LGG increased the expression of Il10 mRNA, encoding the anti-inflammatory cytokine interleukin 10, in the hippocampus. CONCLUSION: Oral LGG altered the abundance of CSF proteins associated with extracellular scaffolding, synaptic plasticity, and glutamatergic signaling. These data are consistent with the hypothesis that oral administration of LGG improves memory and cognition, and promotes a physiological resilience to neurodegenerative disease, by increasing glutamatergic signaling and promoting an anti-inflammatory environment in the brain.
Active coping mitigates the effects of stress on glucocorticoid levels in the prefrontal cortex
Brain Behavior and Immunity · 2025-08-28
articleBrain Behavior and Immunity · 2024-07-21 · 11 citations
articleSenior authorPrior experience with behavioral control over stress facilitates social dominance
Neurobiology of Stress · 2023-12-06 · 2 citations
articleOpen accessDominance status has extensive effects on physical and mental health, and an individual's relative position can be shaped by experiential factors. A variety of considerations suggest that the experience of behavioral control over stressors should produce winning in dominance tests and that winning should blunt the impact of later stressors, as does prior control. To investigate the interplay between competitive success and stressor control, we first examined the impact of stressor controllability on subsequent performance in a warm spot competition test modified for rats. Prior experience of controllable, but not physically identical uncontrollable, stress increased later effortful behavior and occupation of the warm spot. Controllable stress subjects consistently ranked higher than did uncontrollable stress subjects. Pharmacological inactivation of the prelimbic (PL) cortex during behavioral control prevented later facilitation of dominance. Next, we explored whether repeated winning experiences produced later resistance against the typical sequelae of uncontrollable stress. To establish dominance status, triads of rats were given five sessions of warm spot competition. The development of stable dominance was prevented by reversible inactivation of the PL or NMDA receptor blockade in the dorsomedial striatum. Stable winning blunted the later stress-induced increase in dorsal raphe nucleus serotonergic activity, as well as prevented uncontrollable stress-induced social avoidance. In contrast, endocrine and neuroimmune responses to uncontrollable stress were unaffected, indicating a selective impact of prior dominance. Together, these data demonstrate that instrumental control over stress promotes later dominance, but also reveal that winning experiences buffer against the neural and behavioral outcomes of future adversity.
Prior experience with behavioral control over stress facilitates social dominance
bioRxiv (Cold Spring Harbor Laboratory) · 2023-06-07 · 1 citations
preprintOpen accessDominance status has extensive effects on physical and mental health, and an individual's relative position can be shaped by experiential factors. A variety of considerations suggest that the experience of behavioral control over stressors should produce winning in dominance tests and that winning should blunt the impact of later stressors, as does prior control. To investigate the interplay between competitive success and stressor control, we first examined the impact of stressor controllability on subsequent performance in a warm spot competition test modified for rats. Prior experience of controllable, but not physically identical uncontrollable, stress increased later effortful behavior and occupation of the warm spot. Controllable stress subjects consistently ranked higher than did uncontrollable stress subjects. Pharmacological inactivation of the prelimbic (PL) cortex during behavioral control prevented later facilitation of dominance. Next, we explored whether repeated winning experiences produced later resistance against the typical sequelae of uncontrollable stress. To establish dominance status, triads of rats were given five sessions of warm spot competition. Reversible inactivation of the PL or NMDA receptor blockade in the dorsomedial striatum led to a long-term reduction in social rank. Stable dominance blunted the later stress-induced increase in dorsal raphe nucleus serotonergic activity, as well as prevented stress-induced social avoidance. In contrast, endocrine and neuroimmune responses to uncontrollable stress were unaffected, indicating a selective impact of prior dominance. Together, these data demonstrate that instrumental control over stress promotes later dominance, but also reveal that winning experiences buffer against the neural and behavioral outcomes of future adversity.
Brain Behavior and Immunity · 2023-11-03 · 5 citations
articleOpen accessFrom helplessness to controllability: toward a neuroscience of resilience
Frontiers in Psychiatry · 2023 · 40 citations
Senior authorCorresponding- Psychology
- Cognitive psychology
- Neuroscience
produces the debilitation by potent activation of serotonergic neurons in the brainstem dorsal raphe nucleus. Debilitation is prevented with an instrumental controlling response, which activates prefrontal circuitry detecting control and subsequently blunting the dorsal raphe nucleus response. Furthermore, learning control alters the prefrontal response to future adverse events, thereby preventing debilitation and producing long-term resiliency. The general implications of these neuroscience findings may apply to psychological therapy and prevention, in particular by suggesting the importance of cognitions and control, rather than habits of control.
Sex Differences in Stress-Induced Prefrontal Circuit Plasticity
Alcohol · 2023-05-09
articleOpen accessBrain Behavior and Immunity · 2023-04-27 · 14 citations
reviewOpen accessSenior author• SARS-CoV-2 structural proteins are shed from mature virions and enter the circulation. • These proteins produce inflammatory responses in innate immune cells. • Inflammatory responses are mediated by TLR receptors. • These proteins induce inflammatory responses in the periphery and brain. • Inflammatory responses might mediate the neuropsychiatric symptoms in COVID19 patients. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produces an array of neurologic and neuropsychiatric symptoms in the acute and post-acute phase of infection (PASC; post-acute sequelae of SARS-CoV-2 infection). Neuroinflammatory processes are considered key factors in the etiology of these symptoms. Several mechanisms underpinning the development of inflammatory events in the brain have been proposed including SARS-CoV-2 neurotropism and peripheral inflammatory responses (i.e., cytokine storm) to infection, which might produce neuroinflammation via immune-to-brain signaling pathways. In this review, we explore evidence in support of an alternate mechanism whereby structural proteins (e.g., spike and spike S1 subunit) derived from SARS-CoV-2 virions function as pathogen-associated molecular patterns (PAMPs) to elicit proinflammatory immune responses in the periphery and/or brain via classical Toll-Like Receptor (TLR) inflammatory pathways. We propose that SARS-CoV-2 structural proteins might directly produce inflammatory processes in brain independent of and/or in addition to peripheral proinflammatory effects, which might converge to play a causal role in the development of neurologic/neuropsychiatric symptoms in COVID-19.
Neuromethods · 2023-01-01 · 3 citations
book-chapter
Recent grants
NIH · $3.1M · 2007
NIH · $419k · 2018
NIH · $3.8M · 2018
Stress-induced neuroinflammatory priming: Glucocorticoids, inflammasomes, alarmins
NIH · $2.1M · 2016–2023
NIH · $839k · 1996
Frequent coauthors
- 451 shared
Linda R. Watkins
University of Colorado Boulder
- 85 shared
Mark R. Hutchinson
University of Adelaide
- 80 shared
Kenner C. Rice
National Institute on Alcohol Abuse and Alcoholism
- 80 shared
Matthew G. Frank
University of Colorado Boulder
- 65 shared
Erin D. Milligan
University of New Mexico
- 64 shared
Monika Fleshner
University of Colorado Boulder
- 64 shared
Peter M. Grace
The University of Texas MD Anderson Cancer Center
- 58 shared
Ruth M. Barrientos
Labs
1-2 sentence research focus
Education
- 1968
Ph.D.
University of Pennsylvania
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Steven F. Maier
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup